Trials / Enrolling By Invitation
Enrolling By InvitationNCT06977919
NASM OPT for Pectoral Enhancement and Breast Firmness in Non-Athletic Women: An RCT
Efficacy of a 12-Week NASM Optimum Performance Training Program on Pectoral Muscle Strength, Breast Aesthetics, and Low Back Pain in Non-Athletic Women: A Randomized Controlled Trial
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- University of Sistan and Baluchestan · Academic / Other
- Sex
- Female
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This RCT investigates a 12-week NASM OPT program targeting pectoral muscle strength, breast aesthetics (firmness, lift, chest circumference), and low back pain in 120 non-athletic women. The intervention group performed structured resistance training, while the control group engaged in general exercise. Outcomes included pectoral strength (dynamometer), aesthetic satisfaction (Likert scale), and functional performance (push-up test).
Detailed description
Participants were randomized to NASM OPT (3 weekly sessions: stabilization, strength, and hypertrophy phases) or general exercise (brisk walking/aerobics). Measurements at baseline and 12 weeks included pectoral strength, chest circumference, low back pain (VAS), and perceived breast aesthetics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | NASM OPT Program | Three 60-minute weekly sessions for 12 weeks, progressing through stabilization (weeks 1-4), strength endurance (weeks 5-8), and hypertrophy (weeks 9-12) phases. Exercises included bench presses, chest flyes, and push-ups. |
| BEHAVIORAL | General Exercise | Three 60-minute weekly sessions of brisk walking and light aerobics without targeted resistance training. |
Timeline
- Start date
- 2025-05-01
- Primary completion
- 2025-08-15
- Completion
- 2025-09-30
- First posted
- 2025-05-18
- Last updated
- 2025-05-18
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT06977919. Inclusion in this directory is not an endorsement.